Skip to content
Governance Register

← US public companies

Fennec Pharmaceuticals INC.

SEC CIK 1211583 · FENC · last insider filing 2026-06-10

Directors (from insider filings)

NameCapacity as filedFilings
Rallis Chris A Director filed 2017 - 2026
Brughera Marco Maria Director filed 2017 - 2026
Islam Khalid Director filed 2017 - 2026
Cook Jodi A Director filed 2019 - 2026
Raykov Rosty Director · NA filed 2009 - 2026
Andrade Robert Director · Vice President filed 2009 - 2026
Hackman Jeffrey S. Director · Chief Executive Officer filed 2024 - 2026
Haigh Adrian Director · CHIEF OPERATING OFFICER filed 2017 - 2024
Lieberman David B. Director filed 2011 - 2011
Porter Arthur T Director filed 2007 - 2010
Breen William G Director filed 2007 - 2010
Bussandri Claudio F Director filed 2007 - 2010
Butts Robert W Director · Chairman of Board filed 2007 - 2010
Norris Robin J Director · President & COO filed 2007 - 2009
Peters William P Director · Chairman and CEO filed 2007 - 2008
Mermelstein Fred H Director filed 2007 - 2007
Morand Peter Director filed 2007 - 2007
Kufe Donald W Director filed 2007 - 2007
Martin Michael G Director filed 2007 - 2007

Officers (from insider filings)

NameTitle as filedFilings
Evans Terry L Chief Commercial Officer filed 2024 - 2026
Sayad Pierre Sargis Chief Medical Officer filed 2024 - 2026
Cioffi Christiana Marie Chief Strategy Officer filed 2024 - 2026
Goel Shubh Chief Commercial Officer filed 2019 - 2021
Spector Thomas NA filed 2009 - 2010
Murray D Scott SVP, Gen Counsel & Corp Secty filed 2007 - 2008
Klein James A JR CFO filed 2007 - 2008
Solash Jeffrey Chief Licensing Officer filed 2007 - 2007

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.